Bill Detail

H.R. 6294

Congress: 119

Title

Childhood Diabetes Reduction Act of 2025

Summary

Childhood Diabetes Reduction Act of 2025 This bill requires health warnings on labels and in advertisements for food and beverages that are sweetened, processed, or contain a high level of certain nutrients, and it prohibits specifically advertising such products to children. It also expands research and outreach on proper nutrition. The bill requires various Food and Drug Administration (FDA) warnings on labels for (1) sugar-sweetened beverages, (2) food and beverages with non-sugar sweeteners, (3) ultra-processed food and beverages (as defined by the FDA based on recommendations from the National Academies of Science, Engineering, and Medicine), and (4) food and beverages with certain nutrients (e.g., sugar, saturated fat, sodium) at levels that increase health risks. These warnings must contain specified information regarding the risks of developing certain health conditions (e.g., diabetes); warnings for sugar-sweetened beverages and for non-sugar sweetened food and beverages must specifically say that these products are not recommended for children. Additionally, the bill prohibits marketing or advertising these products to children under the Federal Food, Drug, and Cosmetic Act, which is primarily enforced by the FDA. Further, marketing or advertising these products to children, or without the required warnings, is considered an unfair or deceptive trade practice that is subject to action by the Federal Trade Commission (FTC). The bill specifically restores the FTC's statutory authority to regulate advertising targeting children (this authority was limited in 1980). Finally, the bill expands research on nutrition science and requires a public education campaign about nutrition and the new warning labels.

Sponsor

Rep. Donald Beyer [D-VA-8]

Status

Referred to the House Committee on Energy and Commerce.

Status as of Nov 16, 2026, 1:57 PM · synced 7h ago

Introduced

2025-11-25

Data source mode: cache

Bill Engagement

Lobbyists on the case

2 orgs · 27 lobbyists · 4 filings mention H.R. 6294 (Childhood Diabetes Reduction Act of 2025) in LDA disclosures.

These are cached disclosure mentions, not verified current representation or confirmed event attendance.

Top orgs filing
Lobbyists on this bill
+ 25 more in the full intelligence view

Limited preview · paid intelligence

Keep the intelligence current—not just this one record.

Unlock every organization and lobbyist filing on this bill, the complete event and issue map, private team positions, and recurring movement alerts across the portfolio.

Federal Intelligence is $2,500 one-time for three months, or $9,000 for twelve months prepaid, for one named user. Full tracked federal calendar, connected organization/bill/disclosure research, and a private workspace. Fixed terms; no automatic renewal. No demo or scope email is required for standard access.

SEE A FINISHED HEALTHCARE EXAMPLE

Three days of Hill visits. Two Medicare access questions.

A separate, source-linked editorial example—not a dossier about this bill, an endorsement, or a claim of participation. The full records stay paid.

Read the finished healthcare brief →
Buy Federal Intelligence · $2,500 for 3 monthsPrefer a walkthrough first?Already a customer? Sign inGet free intelligence alerts →

After verified successful payment, access is activated within one business day and a secure setup link is emailed. Your term starts at activation. These links do not charge you or unlock records. A free alert subscription does not grant full access.